Oral fluoropyrimidine-based combination therapy in gastrointestinal cancer

ONCOLOGY

Volumn 15, Issue 1 SUPPL. 2, 2001, Pages 79-84

  Vanhoefer, Udo ^a   Wilke, Hansjochen ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORINE DERIVATIVE; PYRIMIDINE DERIVATIVE;

GASTROINTESTINAL TUMOR; HUMAN; ORAL DRUG ADMINISTRATION; REVIEW;

ADMINISTRATION, ORAL; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FLUORINE COMPOUNDS; GASTROINTESTINAL NEOPLASMS; HUMANS; PYRIMIDINES;

EID: 0035229917     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Moertel CG: Chemotherapy for colorectal cancer. N Engl J Med 330:1136-1142, 1994.
2. Machover D: A comprehensive review of 5-fluorouracil and leucovorin in patients with metastatic colorectal carcinoma. Cancer 80:1179-1187, 1997.
3. Rustum YM, Harstrick A, Cao S, et al: Thymidylate synthase inhibitors in cancer therapy: Direct and indirect inhibitors. J Clin Oncol 15:389-400, 1997.
4. Valone FH, Friedman MA, Wittlinger PS, et al: Treatment of patients with advanced colorectal carcinoma with fluorouracil alone, high-dose leucovorin plus fluorouracil, or sequential methotrexate, fluorouracil, and leucovorin: A randomized trial of the Northern California Oncology Group. J Clin Oncol 7:1427-1436, 1989.
5. Advanced Colorectal Cancer Meta-Analysis Project: Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: Evidence in terms of response rate. J Clin Oncol 10:896-903, 1992.